ORGAN AND TISSUE AUTHORITY On 2 July 2008 the Australian Government Accountability Act 2013. announced a national reform program to implement a world’s best practice approach to organ and tissue donation for transplantation. This 27.4 6 was endorsed by the Council of Australian Governments on 3 July 2008. The OTA was established in 2009 to manage FULL-TIME EQUIVALENT STAFF BUSINESS the implementation of the national reform UNITS program. We work with the DonateLife Network, state and territory governments, the broad donation and transplantation clinical In 2016–17 our Senior Executive team comprised: sectors, eye and tissue banks, and community organisations to improve access to » Ms Felicity McNeill PSM (Acting Chief Executive Officer from 14 February 2016 to 2017) transplants for all Australians. A list of key stakeholders with whom we work is » Ms Ann (Acting Chief Executive provided at Appendix 1. Officer from March 2017) The OTA: » Dr Helen Opdam (National Medical Director) » is an independent micro agency within the » Ms Judy Harrison (Chief Financial Officer). Australian Government Health portfolio, At 30 June 2017 the OTA employed 27.4 located in Canberra equivalent staff across six business units. » was established by the Australian Organ Our skilled, expert and dedicated people were and Tissue Donation and Transplantation integral to implementing the national reform which sets out the Authority Act 2008, program and achieving our outcomes and OTA’s primary responsibilities and the strategic priorities in functions of the CEO 2016–17. Our organisational structure for is shown in Figure 1. » is a non-corporate Commonwealth entity the Public Governance, Performance and FIGURE 1: OTA organisational structure MS ANN SMITH | Chief Executive Officer (Acting) DR HELEN OPDAM | Medical Director MS JUDY HARRISON | Chief Financial Officer MARKETING ANALYTICS AND PROJECTS AND LIAISON AND REPORTING SOCIAL
ORGAN AND TISSUE AUTHORITY On 2 July 2008 the Australian Government announced a national reform program to implement a world’s best practice approach to organ and tissue donation for transplantation. This was endorsed by the Council of Australian Governments on 3 July 2008. The OTA was established in 2009 to manage the implementation of the national reform program. We work with the DonateLife Network, state and territory governments, the broad donation and transplantation clinical sectors, eye and tissue banks, and community organisations to improve access to transplants for all Australians. A list of key stakeholders with whom we work is provided at Appendix 1. The OTA: » is an independent micro agency within the Australian Government Health portfolio, located in Canberra » was established by the Australian Organ and Tissue Donation and Transplantation Authority Act 2008, which sets out the OTA’s primary responsibilities and the functions of the CEO » is a non-corporate Commonwealth entity the Public Governance, Performance and Accountability Act 2013. 27.4 6 FULL-TIME EQUIVALENT STAFF BUSINESS UNITS In 2016–17 our Senior Executive team comprised: » Ms Felicity McNeill PSM (Acting Chief Executive Officer from 14 February 2016 to 2017) » Ms Ann (Acting Chief Executive Officer from March 2017) » Dr Helen Opdam (National Medical Director) » Ms Judy Harrison (Chief Financial Officer). At 30 June 2017 the OTA employed 27.4 equivalent staff across six business units. Our skilled, expert and dedicated people were integral to implementing the national reform program and achieving our outcomes and strategic priorities in 2016–17. Our organisational structure for is shown in Figure 1. FIGURE 1: OTA organisational structure MS ANN SMITH | Chief Executive Officer (Acting) DR HELEN OPDAM | Medical Director MS JUDY HARRISON | Chief Financial Officer ANALYTICS AND LIAISON AND REPORTING PROJECTS SOCIAL MARKETING AND
OTA%202016-17%20Annual%20Report%20(Parts%201-2).docx